Plozasiran
VSA001-3001
Phase 3 small_molecule completed
Quick answer
Plozasiran for Familial Chylomicronemia Syndrome is a Phase 3 program (small_molecule) at Arrowhead Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arrowhead Pharmaceuticals Ireland Limited
- Indication
- Familial Chylomicronemia Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed